Home » Stocks » Avinger

Avinger, Inc. (AVGR)

Stock Price: $0.520 USD 0.053 (11.39%)
Updated Aug 5, 2020 9:44 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 28.27M
Revenue (ttm) 8.70M
Net Income (ttm) -19.60M
Shares Out 51.34M
EPS (ttm) -1.55
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 5, 2020
Last Price $0.520
Previous Close $0.467
Change ($) 0.053
Change (%) 11.39%
Day's Open 0.510
Day's Range 0.503 - 0.527
Day's Volume 6,541,435
52-Week Range 0.241 - 1.980

More Stats

Market Cap 28.27M
Enterprise Value 23.83M
Earnings Date (est) Nov 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 51.34M
Float 54.19M
EPS (basic) -1.78
EPS (diluted) -1.55
FCF / Share -0.59
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 220,180
Short Ratio 0.11
Short % of Float 1.10%
Beta 1.28
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 3.25
PB Ratio 5.20
Revenue 8.70M
Operating Income -18.70M
Net Income -19.60M
Free Cash Flow -16.04M
Net Cash 4.44M
Net Cash / Share 0.08
Gross Margin 32.96%
Operating Margin -214.93%
Profit Margin -268.10%
FCF Margin -184.43%
ROA -40.50%
ROE -224.34%
ROIC -223.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 1
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

Current: $0.520
Target: 1.40
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth15.36%-20.32%-48.3%79.35%-4.46%-13.51%51.45%-
Gross Profit2.871.38-3.074.774.244.704.764.41
Operating Income-19.36-23.03-42.55-50.72-40.69-25.03-36.97-33.86
Net Income-19.45-27.56-48.73-56.13-47.34-31.96-39.90-33.86
Shares Outstanding7.
Earnings Per Share-3.18-33.42-749.72-1,355.70-1,751.00-53,273.30-68,208.00-64,812.00
Operating Cash Flow-17.26-18.47-34.48-53.07-40.88-21.80-40.66-35.23
Capital Expenditures-0.07--0.04-0.97-0.58-0.12-0.50-0.29
Free Cash Flow-17.33-18.47-34.52-54.04-41.46-21.92-41.15-35.52
Cash & Equivalents10.9416.415.3936.1043.0612.3212.2220.62
Total Debt8.977.4944.7441.2929.5728.7133.78-
Net Cash / Debt1.988.92-39.36-5.1913.49-16.39-21.5620.62
Book Value6.909.46-35.694.2415.59-144-113-73.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Avinger, Inc.
Country United States
Employees 74
CEO Jeffrey M. Soinski

Stock Information

Ticker Symbol AVGR
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: AVGR
IPO Date January 30, 2015


Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.